The work by Schriner and colleagues is an important
advance in understanding the free radical theory of
aging and its implications for healthy aging and
longevity (1). These investigators created transgenic
mice that overexpress human catalase localized to
peroxisomes, nucleus, and mitochondria, and studied
the effects of aging from birth to death in these
transgenic mouse lines. Interestingly, but not
surprisingly, they found that mice that overexpress
human catalase targeted to mitochondria exhibited
increased life-span 5.5 months longer relative to control
wild-type mice, suggesting that overexpressed catalase
in mitochondria decreases reactive oxygen species
(ROS) and boosts the mitochondrial function. These
events ultimately lead to an extended life-span. This
finding has tremendous implications for healthy aging,
longevity, and age-related illnesses, particularly
Alzheimer’s, Parkinson’s, and ALS.
The free radical theory of aging, one of the prominent
aging hypotheses, holds that during aging, an increase
in ROS in mitochondria causes mutations in the
mitochondrial DNA and damages mitochondrial
components, resulting in senescence. Although tests
of the free-radical theory of aging have provided
conflicting interpretations, findings from recent gene
expression studies (2, 3), mitochondrial DNA studies
(4), and aging animal model studies (5, 6) support this
hypothesis, suggesting that an age-dependent
increase in ROS is a key factor in causing age-related
problems and diseases (7-9).
Schriner and colleagues’ exciting work suggests that
early treatment with antioxidants may help reduce free
radicals and mitochondrial DNA damage and may
increase oxygen consumption in electron transport
chain and ultimately their mitochondrial function. The
use of antioxidant treatments, alone or in combination
with calorie restriction, which has also been found to
reduce ROS and to increase the life-span of rodents
(10), may help reduce mitochondrial toxicity, increase
life-span, and improve health during these increased
years of aging.
Schriner and colleagues’ research demonstrates
increased mitochondrial function in skeletal muscle,
heart, spleen, and other tissues in catalase transgenic
mice relative to control wild-type littermates. It would be
useful to examine changes in the brain in these
transgenic mouse lines in terms of ROS and
mitochondrial function/dysfunction. Further, a
reasonable next step would be to study exact
mechanism(s) of how overexpressed catalase can
reduce ROS within mitochondria, and catalase
interactions with mitochondrial proteins, if any, within
mitochondria. Overall, this study is exciting, with
implications for longevity, treatments for age-related
diseases, and healthy aging.
References
1. S. E. Schriner, N. J. Linford, G. M. Martin, P. Treuting,
C. E. Ogburn, M. Emond, P.E. Oskun, W. Ladiges, N.
Wolf, H. V. Remmen, D. C. Wallace, P. S. Rabinovitch,
Sciencexpress Report (2005)
2. T. Lu, Y. Pan, S.Y. Kao, C. Li, I. Kohane, J. Chan, B.A.
Yankner, Nature 429, 883 (2004).
3. P. H. Reddy, S. McWeeney, B. S. Park, M. Manczak,
R.V. Gutala, D. Partovi, Y. Jung, V. Yau, R. Searles, M.
Mori, J. Quinn, Hum, Mol, Genet. 13, 1225 (2004).
4. M. T. Lin, D. K. Simon, C. H. Ahn, L. M. Kim, M. F. Beal, Hum. Mol. Genet. 11, 133 (2002).
5. A. Trifunovic, A. Wredenberg, M. Falkenberg, J. N.
Spelbrink, A..T. Rovio, C. E. Bruder, Y. M. Bohlooly, S.
Gidlof, A. Oldfors, R. Wibom, J. Tornell, H. T. Jacobs, N.
G. Larsson, Nature 429, 417 (2004).
6. M. Manczak, Y. Jung, B.S. Park, D. Partovi, P. H.
Reddy, J, Neurochem. 292, 494 (2005).
7. R.,H. Swerdlow, S.,M. Khan, Med, Hypotheses 63, 8
(2004).
8. P. H. Reddy, M. F. Beal, Brain Res. Rev., in press.
9. R. W. Taylor, D. M. Turnbull, Nature Rev. Genet. 6, 389
(2005).
10. M. P. Mattson. Annu. Rev. Nutr. (2004), pub ahead
electronic.